Company record
Meridian Bioscience develops and supplies diagnostic equipment and life‑science reagents. Its portfolio comprises monoclonal and polyclonal antibodies, antigens, nucleotides and enzymes, alongside testing platforms for urea‑breath analysis, blood chemistry, immunoassays and molecular diagnostics. The solutions enable detection of cholesterol abnormalities, cancer markers, DNA sequences, as well as respiratory, cardiac and neurological conditions. Meridian Bioscience’s customers include biotechnology firms, hospitals, clinical laboratories, physicians, research institutions and veterinary testing facilities.
This directory record does not yet have a linked material-flow brief.